We found that the percentage of CD4+ PD1+ T lymphocytes in AML patients was not significantly correlated with MRD, and there was no significant correlation between CD8+ PD1+ and MRD (Fig. 5C, D, E and F). This evidence concerns the gene CD8A and acute myeloid leukemia.